Douglas J. Robertson, MD, MPH
Professor of Medicine
Professor of The Dartmouth Institute
The Dartmouth Institute
Georgetown University, BS 1988
U. Connecticut School of Medicine, MD 1992
University of North Carolina, MPH 2000
The Dartmouth Institute for Health Policy and Clinical Practice
VA Medical Center
215 N Main St
Mail Code 111E
White River Junction VT 05009
Office: 802 295 9363
Colorectal Cancer Epidemiology and Outcomes
Pharmacoepidemiology of GI disease
1.Prospective Evaluation of Risk Factors for Large (≥ 1cm) Colonic Adenomas in Asymptomatic Subjects. A large multicenter trial funded by the VA Cooperative Studies Program. Principal Investigator: David Lieberman. (Role: Site PI)
2.Translation of Colorectal Cancer Screening Guidelines to Practice-A System Intervention. A multicenter trial funded by the VA Colorectal Cancer Queri. Principal Investigator: Linda Humphrey. (Role Site PI)
3.Colorectal Chemoprevention with Calcium and Vitamin D. A large randomized placebo controlled trial funded by the National Institutes of Health. Principal Investigator: John Baron (Role Clinical Director)
4.Developing Sensible Screening Strategies Following Colonoscopy. VA Health Services Research & Development Career Development Award (Principal Investigator)
Scientific Basis of Medicine-GI Section
Baseline Colonoscopy Findings Associated with 10-Year Outcomes in a Screening Cohort Undergoing Colonoscopy Surveillance.
Overuse of Cystoscopic Surveillance Among Patients With Low-risk Non-Muscle-invasive Bladder Cancer - A National Study of Patient, Provider, and Facility Factors.
The impact of frequent cystoscopy on surgical care and cancer outcomes among patients with low-risk, non-muscle-invasive bladder cancer.
No Evidence for Posttreatment Effects of Vitamin D and Calcium Supplementation on Risk of Colorectal Adenomas in a Randomized Trial.
Metachronous Neoplasias Arise in a Higher Proportion of Colon Segments From Which Large Polyps Were Previously Removed, and Can be Used to Estimate Incomplete Resection of 10-20 mm Colorectal Polyps.
Opportunities and Challenges in Moving From Current Guidelines to Personalized Colorectal Cancer Screening.
Extent of Risk-Aligned Surveillance for Cancer Recurrence Among Patients With Early-Stage Bladder Cancer.
Learning to be More Positive About FIT.
Body mass index, calcium supplementation and risk of colorectal adenomas.
Monitoring compliance with colorectal cancer screening: Do we have it covered?